BEAM Q2 2019 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000

Gross Profit

-$13M-211233.3% margin

Operating Income

-$18M-294183.3% margin

Net Income

-$18M-297683.3% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$181M

Total Liabilities

$37M

Stockholders' Equity

$144M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,000	$0	—
Gross Profit	-$13M	-$7M	-78.9%
Operating Income	-$18M	-$10M	-81.1%
Net Income	-$18M	-$10M	-76.3%